| 000 | 02786 a2200817 4500 | ||
|---|---|---|---|
| 005 | 20250516063414.0 | ||
| 264 | 0 | _c20120427 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1096-9896 | ||
| 024 | 7 |
_a10.1002/path.3035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurlong, Fiona | |
| 245 | 0 | 0 |
_aLow MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer. _h[electronic resource] |
| 260 |
_bThe Journal of pathology _cApr 2012 |
||
| 300 |
_a746-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3' Untranslated Regions |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCarcinoma, Ovarian Epithelial |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMad2 Proteins |
| 650 | 0 | 4 |
_aMicroRNAs _xmetabolism |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms, Cystic, Mucinous, and Serous _xgenetics |
| 650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xdrug therapy |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aParaffin Embedding |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRepressor Proteins _xgenetics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFitzpatrick, Patricia | |
| 700 | 1 | _aO'Toole, Sharon | |
| 700 | 1 | _aPhelan, Sine | |
| 700 | 1 | _aMcGrogan, Barbara | |
| 700 | 1 | _aMaguire, Aoife | |
| 700 | 1 | _aO'Grady, Anthony | |
| 700 | 1 | _aGallagher, Michael | |
| 700 | 1 | _aPrencipe, Maria | |
| 700 | 1 | _aMcGoldrick, Aloysius | |
| 700 | 1 | _aMcGettigan, Paul | |
| 700 | 1 | _aBrennan, Donal | |
| 700 | 1 | _aSheils, Orla | |
| 700 | 1 | _aMartin, Cara | |
| 700 | 1 | _aW Kay, Elaine | |
| 700 | 1 | _aO'Leary, John | |
| 700 | 1 | _aMcCann, Amanda | |
| 773 | 0 |
_tThe Journal of pathology _gvol. 226 _gno. 5 _gp. 746-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/path.3035 _zAvailable from publisher's website |
| 999 |
_c21298260 _d21298260 |
||